retatrutide or tirzepatide vs (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Retatrutide vs. Tirzepatide: What's The

matches Phase 3 retatrutide cadence Cycle driver CJC/Ipa cycled 12 weeks on / 4 weeks off Retatrutide Loading 2 mg/week (weeks 1-4) Frequency 1x weekly Maintenance 9-12 mg/week (weeks 17-20+) Route SubQ

The difference between a dose that is 10% too high and one that is 10% too low might come down to which syringe you selected

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

Clinical Relevance: A Comprehensive Approach Both drugs appear poised to redefine obesity pharmacotherapy

This mechanism is central to how GLP-1 receptor agonistsmedications that mimic natural GLP-1work to regulate blood glucose levels and promote weight loss

If you have received injections for several weeks and notice no change, tell your provider